Immunovant Swaps Out Lead Assets

switching directions
Immunovant is switching its lead asset • Source: Shutterstock (Stockimo/Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business